Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Karen Augustine"'
Autor:
Faye Wang, Cindy Zhang, Jae Kwagh, Brian Strassle, Jinqing Li, Minxue Huang, Yunling Song, Brenda Lehman, Richard Westhouse, Kamalavenkatesh Palanisamy, Vinay K. Holenarsipur, Robert Borzilleri, Karen Augustine-Rauch
Publikováno v:
iScience, Vol 24, Iss 3, Pp 102133- (2021)
Summary: This study focused on characterizing the potential mechanism of valvular toxicity caused by TGFβ receptor inhibitors (TGFβRis) using rat valvular interstitial cells (VICs) to evaluate early biological responses to TGFβR inhibition. Three
Externí odkaz:
https://doaj.org/article/a68cd93dd958438cb620f93aecf70450
Autor:
Shiuhang Yip, Emily Luk, Anwar Murtaza, Yong Zhang, Michael A. Poss, Louis J. Lombardo, Nimmi Raghavan, Zheng Yang, James Kempson, Audris Huang, David R. Tortolani, Jesse Swanson, Xiaoping Hou, Joseph Pawluczyk, James Smalley, Honghe Wan, Karen E. Parrish, Robert M. Borzilleri, Ashok V. Purandare, Karen Augustine-Rauch, Andrew F. Donnell
Publikováno v:
Journal of Medicinal Chemistry. 64:15787-15798
Inhibition of TGFβ signaling in concert with a checkpoint blockade has been shown to provide improved and durable antitumor immune response in mouse models. However, on-target adverse cardiovascular effects have limited the clinical use of TGFβ rec
Autor:
Jennifer Brown, Karen E. Parrish, Andrew J. Tebben, Jonathan Lippy, Kamalavenkatesh Palanisamy, Todd Kinsella, Chetan Padmakar Darne, Vinay K. Holenarsipur, Anwar Murtaza, Muthalagu Vetrichelvan, Chunhong Yan, Karen Augustine-Rauch, Max Ruzanov, Mark Fereshteh, Upender Velaparthi, Gopal Dhar, Gregory D. Vite, Peiying Liu, Steven Sheriff, Jayakumar Sankara Warrier, Aravind Anandam, Marina Gelman, Arvind Mathur, Barri Wautlet, Robert M. Borzilleri, Hasibur Rahaman, Zheng Yang, Anuradha Gupta, Arun Kumar Gupta, Rajinder Singh, Joseph Fargnoli, Jesse Swanson
Publikováno v:
ACS Med Chem Lett
[Image: see text] Novel imidazole-based TGFβR1 inhibitors were identified and optimized for potency, selectivity, and pharmacokinetic and physicochemical characteristics. Herein, we report the discovery, optimization, and evaluation of a potent, sel
Autor:
Scott Engel, K. Turner, Marlowe J. Schneidkraut, Brian P. Enright, Karen Augustine-Rauch, Mary Ellen McNerney, Paul Barrow, S. Powlin, K. Brannen, Bruce K. Beyer, Michael J. Graziano, David Potter, William S. Nowland, Dinesh Stanislaus, Nicola Powles-Glover
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 124
An IQ DruSafe working group evaluated the concordance of 3 alternative teratogenicity assays (rat whole embryo culture, rWEC; zebrafish embryo culture, ZEC; and murine embryonic stem cells, mESC) with findings from rat or rabbit embryo-fetal developm
Autor:
Richard A. Westhouse, Faye Wang, Jae Kwagh, Brian Strassle, Cindy X. Zhang, Robert M. Borzilleri, Minxue Huang, Vinay K. Holenarsipur, Yunling Song, Kamalavenkatesh Palanisamy, Karen Augustine-Rauch, Jinqing Li, Brenda L. Lehman
Publikováno v:
iScience
iScience, Vol 24, Iss 3, Pp 102133-(2021)
iScience, Vol 24, Iss 3, Pp 102133-(2021)
Summary This study focused on characterizing the potential mechanism of valvular toxicity caused by TGFβ receptor inhibitors (TGFβRis) using rat valvular interstitial cells (VICs) to evaluate early biological responses to TGFβR inhibition. Three T
Publikováno v:
Toxicology and applied pharmacology. 411
Pexacerfont is a corticotrophin-releasing factor subtype 1 receptor (CRF-1) antagonist developed for potential treatment of anxiety and stress-related disorders. In male rats, pexacerfont caused hepatic enzyme induction leading to increased thyroxine
Autor:
Courtni Newsome, Gregory D Rak, Michael J. Graziano, Gene E. Schulze, Melvin R. White, Karen Augustine-Rauch
Publikováno v:
Journal of applied toxicology : JATREFERENCES. 40(7)
Small-molecule inhibitors of transforming growth factor beta receptor 1 (TGFβRI) have a history of significant class-based toxicities (eg, cardiac valvulopathy) in preclinical species that have limited their development as new medicines. Nevertheles
Publikováno v:
Birth Defects Research Part B: Developmental and Reproductive Toxicology. 107:4-20
Increasing need for proactive safety optimization of pharmaceutical compounds has led to generation and/or refinement of in vitro developmental toxicology assays. Our laboratory has developed three in vitro developmental toxicology assays to assess t
Autor:
Cindy X. Zhang, Danielle Greenawalt, Ke Xu, Julie Panzica-Kelly, Richard A. Westhouse, Ronald Fleming, Ashvinikumar V. Gavai, Jennifer Price, Denise Bounous, Shodeinde Coker, Karen Augustine-Rauch, Kezi Unsal-Kacmaz
Publikováno v:
Cancer Research. 80:1742-1742
Bromodomain and extraterminal (BET) proteins recognize acetylated lysine residues for the purpose of transcriptional regulation of genes, including those involved in stem cell renewal and oncogenes such as MYC. Inhibition of BET proteins BRD2, BRD3,
Autor:
Yufen Zhao, Barri Wautlet, Jonathan Lippy, Anne Rose, Andrew J. Tebben, Gregory D. Vite, Max Ruzanov, Joseph Fargnoli, Liping Zhang, Yong Zhang, Zheng Yang, Karen E. Parrish, Robert M. Borzilleri, Yi Fan, Jesse Swanson, Ching-Ping Ho, Karen Augustine-Rauch, Andrew F. Donnell, Brian E. Fink, Steven Sheriff, Mark Fereshteh
[Image: see text] The multifunctional cytokine TGFβ plays a central role in regulating antitumor immunity. It has been postulated that inhibition of TGFβ signaling in concert with checkpoint blockade will provide improved and durable immune respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca61cd13f527f4d17df3df6c932c4f3
https://europepmc.org/articles/PMC6231184/
https://europepmc.org/articles/PMC6231184/